Besides exocrine glands involvement, extraglandular manifestations are widely variable, such as arthralgia, myalgia, fatigue and purpura. Even vital organs can be impacted, including interstitial pneumonia, pericarditis, pulmonary hypertension nephritis and neuropathy. 3 Although the etiology and pathogenesis of pSS are still obscure, the proliferation of B-lymphocytes in exocrine glands and extra-glandular epithelia have been confirmed. 4 Therefore, more and more concern has been drawn upon the development of lymphoproliferative disorders. 5 Compared to other systemic complications, renal involvement is less frequent with prevalence ranging from 2%
to 67% due to different definitions of kidney involvement. [6] [7] [8] pSS is
reported to precede renal manifestations by a median of 5.5 years in a renal biopsy study of 25 patients. 9 Renal involvement in pSS significantly manifests with tubulointerstitial nephritis (TIN) as a result of epithelial disease with significant lymphocytic infiltration which appears to be mainly CD4 + T cells. 10 Clinical features of renal involvement in pSS have varied widely, 11 and the relationship between the associated factors and renal involvement is seldom investigated. Therefore, we conducted the present study to characterize the demographic, clinical, histological and immunological features of patients with renal involvement in pSS. Furthermore, we investigated the clinical feature and laboratory index which are potentially associated with renal involvement in pSS to facilitate a comprehensive disease evaluation and prevention for pSS patients.
| MATERIAL S AND ME THODS

| Study population
We Commission of China ethical standards. In addition, we received written informed consent from all patients prior to enrollment in the study.
| Evaluation of exocrine gland involvement
A detailed history was reviewed and physical examination was taken by the rheumatologists before the pSS patient was recruited into the study. 
| Data collection and statistical analysis
All data were collected, including demographics, clinical assessment, pathologic findings, and serologic results. We expressed continuous data which fit normal distribution as mean ± standard deviation.
Paired comparison of these data was performed using the t test. erythrocyte sedimentation rate (ESR) and ESSDAI levels and reduced hemoglobin were found in the renal-involved patients.
| Renal manifestations in pSS
Renal manifestations and proportions are presented in Table 2 .
Almost half of the renal-involved pSS patients had mild and medium
. Hematuria (29.5%) and hyposthenuria (17.5%)
were also common when tested by routine urine analysis. The serum levels of albumin, creatinine and creatinine clearance rate were Thirty patients with positive findings by urine analysis in the subgroup received renal biopsy after informed consent. As is shown in 
| Characteristics of high titer ANA-positive patients in pSS with renal involvement
As shown in Table 4 , high titer ANA (1:320) was more common (58.99%) in the renal-involved pSS. Also, the ANA-positive subgroup had a higher female proportion, more cutaneous domain involvement and positive histological findings of LSGB.
Unsurprisingly, patients with ANA positivity presented higher anti-SSA/SSB and RF positive rates and increased IgA levels.
However, the ANA negative subgroup manifested more severe renal impairment with much lower creatinine clearance rate (CCR) levels, but without significant difference in ESSDAI with the positive subgroup.
| Features of different histological patterns of LSGB in pSS with kidney involvement
As shown in Table 5 , positive histological findings (lymphocytic focus score ≥1) were detected in 73.27% of the pSS patient with renal involvement. General manifestation like fatigue was more common in the histologically positive group (P < 0.05). Also, this subgroup had much higher levels of ESSDAI, IgG, lower level of hemoglobin and CCR, and more frequent low C3 levels prevalence (P < 0.05). All Hyperuricemia, >420 mmol/L, n (%) 9 (4.15)
CCR, creatinine clearance rate; SCR, serum creatinine. Data are presented as mean ± standard deviation or as n (%).
Glomerular lesion manifestations Tubular manifestations Case number
Minimally invasive glomerulopathy -2
Immunoglobulin A nephropathy, mesangial proliferative glomerulonephritis with focal segmental glomerulosclerosis -4
Mesangial proliferative glomerulonephritis with focal segmental glomerulosclerosis TA B L E 3 Histological manifestations of renal involvement in primary Sjögren's syndrome these indices suggested much more severe conditions in these patients than the negative subgroup.
| Specific factors associated with renal involvement in pSS
The associations between the various factors in pSS patients with renal involvement were first assessed using univariate analyses (Table 6 ). Several factors were significantly associated with renal involvement, including xerophthalmia, positive histological findings of LSGB, anti-SSA/Ro52 positivity, IgG level, reduced C3 levels (C3 < 0.80 g/L), ESR level, hypoalbuminemia and anemia (all P < 0.05).
To avoid interference from potentially related factors, these factors associated with renal involvement were further analyzed by multivariate analyses (Table 7 ). In the multivariate analysis, xerophthalmia, histological positivity of LSGB, anti-SSA/Ro52 positivity, reduced C3 levels, hypoalbuminemia and anemia retained significant association with renal involvement in pSS (all P < 0.05). Interestingly, xerophthalmia and anti-SSA/Ro52 positivity were negatively associated with renal involvement in pSS.
| D ISCUSS I ON
To date our study represents one of the largest cross-sectional study cohorts of Chinese pSS patients with renal involvement. Till now, few studies have specially investigated the renal features and potential factors associated with renal involvement in pSS patients.
Our cohort has a higher prevalence of renal involvement in women but with similar onset ages and disease duration compared with a previous study. 9 However, there was lower anti-SSA/RO-52 positivity compared to previous reports 22, 23 (49.07% vs 72.2%~77.1%).
Also the pulmonary involvement was varied from these two studies.
Whether this difference is due to genetic, territorial causes or definition of renal involvement warrants further investigation.
Within our cohort, the renal-involved pSS patients displayed a distinctive clinical profile with higher disease activity (ESSDAI), more LSGB positivity and elevated inflammation levels (as reflected by ESR), but lower xerophthalmia prevalence compared with their ageand gender-matched nonrenal-involved controls.
Antinuclear antibodies positivity was defined in our cohort as a 1:320 titer or higher to exclude low titer ANA positivity as it's not so specific especially in older people or those with other chronic profiling have good diagnostic properties for pSS. 24 Therefore, high titer ANA positivity is much more significant in pSS. In our study, high titer ANA positivity was more common in renal-involved pSS patients with a higher proportion of cutaneous involvement, although the total incident rate of cutaneous involvement in pSS patients was not as high as reported in previous studies. 25, 26 Moreover, the ANA positive subgroup indicated elevated levels of IgA and RF, and were consistent with higher LSGB positivity just as previously reported. 27 Of note, in our study, more severe renal impairment was observed in the ANA negative subgroup. The reason is still not clear, so more attention should be given to those without significant immunological antibody.
Lymphocytic infiltration in the labial gland with a focus score of ≥1 per 4 mm 2 is the phenotypic feature of pSS. 28 In the histopathologically positive subgroup, a mean ESSDAI of 7.67 was observed, indicating medium disease activity. Importantly, a majority of renalinvolved pSS patients had positive histopathology, in accordance with higher proportion of ESSDAI index, anemia, elevated level of IgG and low level of C3, indicating a close correlation between histological patterns and severity and activity of the disease in those patients, which was also found in whole pSS cohorts in previous studies. 29, 30 Higher SGUS (salivary gland ultrasonography) score (3 and 4) has already been found to be was associated with elevated IgG (>1600 mg/dL) and ESSDAI (≥5) levels, further suggesting the relationship between disease severity and dysfunction of the salivary gland. Despite an incomplete variant of the disease and retaining normal serum bicarbonate levels, all of these types have an alkaline urine pH 34 ; therefore we used urine pH as a requisite, although this was not sufficient feature in the present study to reflect tubulointerstitial involvement. It was revealed that 80.2% of the renal-involved cohort got urine pH >6.0, implying the high prevalence of TIN in pSS.
However, glomerular disease is far from rare in our cohort. Renal biopsy revealed diverse pathological findings, including membranoproliferative glomerulonephritis (MPGN), membranous nephropathy (MN), minimal change disease, IgA nephropathy, and so on. The etiology and pathogenesis of the glomerular disease in pSS are unclear but may be related to the deposition of circulating immune complexes, even underlying cryoglobulinemia with a late sequela and a less favorable prognosis. 35, 36 As proteinuria is much more likely to be indicative of renal biopsy than the typical clinical characteristic of TIN, more glomerular disease, especially MN, was found by renal biopsy. The prognosis of patients with predominantly glomerular involvement was found to be worse with lower survival rates and a higher incidence of lymphoma, 37,38 so renal biopsy is still suggested for those with suspicious glomerular disease.
Renal involvement is hard to foresee but directly influences the prognosis of pSS patients. In our study, xerophthalmia, positivity of labial gland biopsy, anti-SSA/Ro52 positivity, reduced C3 levels, hypoalbuminemia and anemia had been confirmed to be significantly associated with renal involvement in pSS by univariate and multivariate analyses. Of note, xerophthalmia manifested negative association with renal involvement, which was also found in a previous study. 23 Also, anti-SSA/Ro52 positivity was also found negatively associated with renal involvement in our study. The reasons are still unclear, and further studies are required. It's presumed that uncontrolled activation of the complement pathway leads to predominantly glomerular deposition of C3, which is called C3 glomerulopathy. 39 Based on that, we believe reduced C3 levels, as a result of overconsuming, may be highly associated with renal involvement. Anemia in pSS can be caused by autoimmune hemolysis, iron deficiency, chronic diseases, like kidney disease, and so on. It's suggested to measure hemoglobin in patients with impaired renal function to identify those with a higher risk of having or developing anemia, and to assess renal function using a simple and reliable formula based on their mutual relationship, which accords with our study. 40 Furthermore, anemia TA B L E 7 Multivariable analysis of factors associated with renal involvement in primary Sjögren's syndrome and hypoalbuminemia were associated with increased risk of morbidity and mortality in end-stage renal disease, 41 which seems to fit in with our findings.
Our study may have several limitations. First, limited pSS with renal involvement patients had renal biopsy which could create selection bias, and might lead to a high prevalence of the glomerulonephritis pattern. Also, as a cross-section study, our study is only limited to making correlation analysis rather than causality analysis.
For example, it's difficult to determine whether anemia and hypoproteinemia are the causes or results of renal involvement in pSS.
Future multi-center prospective studies are needed to confirm our findings.
In conclusion, chronic tubulointerstitial inflammation is the most typical renal manifestation in pSS, while glomerular involvement is also frequent. Positive labial gland biopsy is highly associated with renal lesions. Other factors, including anti-SSA/Ro52 positivity, reduced C3 levels, hypoalbuminemia and anemia, also indicate a significant association with renal involvement in pSS.
Therefore, early vigilance is required for patients with these clinical manifestations.
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